» Articles » PMID: 37331955

[Research Progress on the Role of Chondrocyte Mitochondrial Homeostasis Imbalance in the Pathogenesis of Osteoarthritis]

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To summarize the role of chondrocyte mitochondrial homeostasis imbalance in the pathogenesis of osteoarthritis (OA) and analyze its application prospects.

Methods: The recent literature at home and abroad was reviewed to summarize the mechanism of mitochondrial homeostasis imbalance, the relationship between mitochondrial homeostasis imbalance and the pathogenesis of OA, and the application prospect in the treatment of OA.

Results: Recent studies have shown that mitochondrial homeostasis imbalance, which is caused by abnormal mitochondrial biogenesis, the imbalance of mitochondrial redox, the imbalance of mitochondrial dynamics, and damaged mitochondrial autophagy of chondrocytes, plays an important role in the pathogenesis of OA. Abnormal mitochondrial biogenesis can accelerate the catabolic reaction of OA chondrocytes and aggravate cartilage damage. The imbalance of mitochondrial redox can lead to the accumulation of reactive oxygen species (ROS), inhibit the synthesis of extracellular matrix, induce ferroptosis and eventually leads to cartilage degradation. The imbalance of mitochondrial dynamics can lead to mitochondrial DNA mutation, decreased adenosine triphosphate production, ROS accumulation, and accelerated apoptosis of chondrocytes. When mitochondrial autophagy is damaged, dysfunctional mitochondria cannot be cleared in time, leading to ROS accumulation, which leads to chondrocyte apoptosis. It has been found that substances such as puerarin, safflower yellow, and astaxanthin can inhibit the development of OA by regulating mitochondrial homeostasis, which proves the potential to be used in the treatment of OA.

Conclusion: The mitochondrial homeostasis imbalance in chondrocytes is one of the most important pathogeneses of OA, and further exploration of the mechanisms of mitochondrial homeostasis imbalance is of great significance for the prevention and treatment of OA.

Citing Articles

Recent development of mitochondrial metabolism and dysfunction in osteoarthritis.

Guo P, Alhaskawi A, Adel Abdo Moqbel S, Pan Z Front Pharmacol. 2025; 16:1538662.

PMID: 40017603 PMC: 11865096. DOI: 10.3389/fphar.2025.1538662.


From dysfunction to healing: advances in mitochondrial therapy for Osteoarthritis.

Zhang M, Wu J, Cai K, Liu Y, Lu B, Zhang J J Transl Med. 2024; 22(1):1013.

PMID: 39529128 PMC: 11552139. DOI: 10.1186/s12967-024-05799-z.

References
1.
Lee H, Yoon Y . Mitochondrial fission and fusion. Biochem Soc Trans. 2016; 44(6):1725-1735. DOI: 10.1042/BST20160129. View

2.
Chen L, Wang Y, Terkeltaub R, Liu-Bryan R . Activation of AMPK-SIRT3 signaling is chondroprotective by preserving mitochondrial DNA integrity and function. Osteoarthritis Cartilage. 2018; 26(11):1539-1550. PMC: 6202232. DOI: 10.1016/j.joca.2018.07.004. View

3.
Lepetsos P, Papavassiliou A . ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016; 1862(4):576-591. DOI: 10.1016/j.bbadis.2016.01.003. View

4.
Burkhardt H, Schwingel M, Menninger H, Macartney H, Tschesche H . Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum. 1986; 29(3):379-87. DOI: 10.1002/art.1780290311. View

5.
Vinatier C, Merceron C, Guicheux J . Osteoarthritis: from pathogenic mechanisms and recent clinical developments to novel prospective therapeutic options. Drug Discov Today. 2016; 21(12):1932-1937. DOI: 10.1016/j.drudis.2016.08.011. View